Lead author of the TRIANGLE study, Dr. Dreyling, who is Associate Professor of Medicine at the University of Munich, leads listeners through the management of mantle cell lymphoma (MCL) in newly diagnosed patients, in this episode of “Blood Cancer Talks.”
Dr. Dreyling also answers questions on treating patients without access to upfront ibrutinib access as per the TRIANGLE trial, if allogeneic transplant has a role in MCL, and more.